Factors Associated With PASI90 Maintenance Without Flare-Up and Predictors of Biologics Discontinuation in Psoriasis: Two-Center Retrospective Cohort Study in Korea. [PDF]
Choi MS +5 more
europepmc +1 more source
Biologics and Drug-Induced Immunogenicity: A Case Report of Acquired Hemophilia A Presenting After Immunotherapy. [PDF]
Murgas KA +4 more
europepmc +1 more source
A Retrospective Review of Real-World Patterns of Biologic Use in Dermatology Across Metropolitan, Regional and Rural Settings. [PDF]
Abeysekera N +5 more
europepmc +1 more source
Clinical practice guideline for psoriasis management in Latin America. [PDF]
Valenzuela F +16 more
europepmc +1 more source
Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis. [PDF]
Yang N +12 more
europepmc +1 more source
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry. [PDF]
Wen J +5 more
europepmc +1 more source
Prevalence and clinical relevance of anti-drug antibodies in psoriatic arthritis: a systematic review. [PDF]
Kimpton J +6 more
europepmc +1 more source
Efficacy of tofacitinib in the treatment of refractory palmoplantar psoriasis (non-pustular): case report and literature review. [PDF]
Sakiyama PH, Miot LDB, Miot HA.
europepmc +1 more source
Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report. [PDF]
Medina-Figueroa MD +4 more
europepmc +1 more source

